Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF)

Market Closed
10 Aug, 15:25
TASE TASE
508. 20
ILA
-21.5
-4.0589%
ILA
49.38M Market Cap
- P/E Ratio
- Div Yield
2,840 Volume
- Eps
529.7 ILA
Previous Close
Add Transaction
Day Range
506 529.7
Year Range
374 3,000
Want to track CANF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
12 Apr 2026
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
26 Mar 2026
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
28 Aug 2025
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
26 Mar 2025
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
28 Nov 2024
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
29 Aug 2024
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
30 May 2024
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
28 Mar 2024
-
-
Can-Fite BioPharma Ltd. logo
CANF Can-Fite BioPharma Ltd.
23 Nov 2023
-
-

CANF Earnings Reports FAQ

What is the earnings per share (EPS) for CANF?

EPS data for CANF is currently not available, as Can-Fite BioPharma Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Can-Fite BioPharma Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Can-Fite BioPharma Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Can-Fite BioPharma Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for CANF at this time, as Can-Fite BioPharma Ltd has no recent EPS data to calculate it.